These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12840828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.
    Kugelberg FC, Kingbäck M, Carlsson B, Druid H.
    J Anal Toxicol; 2005; 29(4):223-8. PubMed ID: 15975250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
    Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P.
    Biochem Pharmacol; 1998 Jul 01; 56(1):15-23. PubMed ID: 9698084
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
    Wikell C, Apelqvist G, Carlsson B, Hjorth S, Bergqvist PB, Kugelberg FC, Ahlner J, Bengtsson F.
    Clin Neuropharmacol; 1999 Jul 01; 22(6):327-36. PubMed ID: 10626092
    [Abstract] [Full Text] [Related]

  • 6. In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.
    Kugelberg FC, Apelqvist G, Carlsson B, Ahlner J, Bengtsson F.
    Br J Pharmacol; 2001 Apr 01; 132(8):1683-90. PubMed ID: 11309239
    [Abstract] [Full Text] [Related]

  • 7. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy.
    Apelqvist G, Wikell C, Carlsson B, Hjorth S, Bergqvist PB, Ahlner J, Bengtsson F.
    Clin Neuropharmacol; 2000 Apr 01; 23(6):304-17. PubMed ID: 11575864
    [Abstract] [Full Text] [Related]

  • 8. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.
    Berzas-Nevado JJ, Villaseñor-Llerena MJ, Guiberteau-Cabanillas C, Rodríguez-Robledo V.
    Electrophoresis; 2006 Feb 01; 27(4):905-17. PubMed ID: 16470634
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.
    Reis M, Lundmark J, Bengtsson F.
    Ther Drug Monit; 2003 Apr 01; 25(2):183-91. PubMed ID: 12657912
    [Abstract] [Full Text] [Related]

  • 10. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC.
    Rochat B, Amey M, Van Gelderen H, Testa B, Baumann P.
    Chirality; 1995 Apr 01; 7(6):389-95. PubMed ID: 7577348
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats.
    Kingbäck M, Carlsson B, Ahlner J, Bengtsson F, Kugelberg FC.
    Chirality; 2011 Feb 01; 23(2):172-7. PubMed ID: 20848647
    [Abstract] [Full Text] [Related]

  • 12. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
    Tanum L, Strand LP, Refsum H.
    Pharmacopsychiatry; 2010 Jul 01; 43(5):190-3. PubMed ID: 20503148
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic consequences of a citalopram treatment discontinuation.
    Voirol P, Rubin C, Bryois C, Kosel M, Buclin T, Baumann P.
    Ther Drug Monit; 1999 Jun 01; 21(3):263-6. PubMed ID: 10365634
    [Abstract] [Full Text] [Related]

  • 14. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
    Sidhu J, Priskorn M, Poulsen M, Segonzac A, Grollier G, Larsen F.
    Chirality; 1997 Jun 01; 9(7):686-92. PubMed ID: 9366029
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    Foglia JP, Pollock BG, Kirshner MA, Rosen J, Sweet R, Mulsant B.
    Psychopharmacol Bull; 1997 Jun 01; 33(1):109-12. PubMed ID: 9133760
    [Abstract] [Full Text] [Related]

  • 16. Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics.
    Rocha A, Marques MP, Coelho EB, Lanchote VL.
    Chirality; 2007 Nov 01; 19(10):793-801. PubMed ID: 17722014
    [Abstract] [Full Text] [Related]

  • 17. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
    Unceta N, Goicolea MA, Barrio RJ.
    Biomed Chromatogr; 2011 Jan 01; 25(1-2):238-57. PubMed ID: 21058412
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.
    Reis M, Olsson G, Carlsson B, Lundmark J, Dahl ML, Wålinder J, Ahlner J, Bengtsson F.
    J Clin Psychopharmacol; 2002 Aug 01; 22(4):406-13. PubMed ID: 12172341
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
    Kosel M, Eap CB, Amey M, Baumann P.
    J Chromatogr B Biomed Sci Appl; 1998 Nov 20; 719(1-2):234-8. PubMed ID: 9869386
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.